免疫抑制微环境由质瘤相关的介质干细胞调节:目前的状况和潜在的战略
Yuyi Wu1, Qiang Liu1, Wei Xiang1
1Department of Neurosurgery, Wuhan Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Biochimica et biophysica acta. Reviews on cancer
|August 8, 2025
概括
质瘤相关的介质干细胞 (GA-MSCs) 创造了一个免疫抑制瘤微环境 (TME),促进质瘤的生长. 然而,这些细胞也为脑瘤治疗提供了治疗潜力.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
背景情况:
- 质瘤是一种致命的脑瘤,预后不好,通常是由于其免疫抑制性瘤微环境 (TME).
- 质瘤关联介质干细胞 (GA-MSCs) 是质瘤TME中的关键参与者,在瘤进展和免疫逃避中表现出双重作用.
研究的目的:
- 审查GA-MSCs在调节质瘤TME中的多方面的作用.
- 探索GA-MSCs在质瘤治疗中的治疗潜力,并讨论相关挑战.
主要方法:
- 对研究GA-MSC相互作用在质瘤TME中的研究的文献综述.
- 分析GA-MSCs影响免疫细胞,质瘤干细胞和血管生成的机制.
- 基于GA-MSC的治疗策略及其临床局限性的评估.
主要成果:
- GA-MSCs通过通过可溶性因子和细胞接触与免疫细胞相互作用来抑制抗瘤免疫力.
- GA-MSCs通过增强干性,侵入性,化学抵抗性和血管生成来促进质瘤的进展.
- 基因改造的GA-MSC显示出针对性治疗,细胞因子分泌和免疫反应增强的前景.
结论:
- GA-MSCs在质瘤中具有复杂的点,有助于瘤进展和治疗机会.
- 克服免疫抑制活性和传递效率等挑战对于GA-MSC基础疗法的成功临床转化至关重要.
- 针对GA-MSC及其在TME中的相互作用,可能会导致新的和有效的质瘤治疗方法.
相关概念视频
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


